Parallel Bio Cofounder Robert DiFazio on the AI problem in drug discovery: "What's interesting about AI is it's a very one-sided conversation. Everybody's focused on the frontier models, which are incredibly exciting and powerful, but people forget the other half, which is data. It's the same as with original computers, GIGO, garbage in, garbage out. You could have the world's most powerful computer, but if you're feeding it garbage, that's what comes out." "A potential issue with AI in a lot…